These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation. Gorla R, Erbel R, Kuehl H, Kahlert P, Tsagakis K, Jakob H, Mahabadi AA, Schlosser T, Bockisch A, Eggebrecht H, Bossone E, Jánosi RA. Int J Cardiovasc Imaging; 2015 Dec; 31(8):1677-85. PubMed ID: 26220267 [Abstract] [Full Text] [Related]
23. Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation. Oh M, Lee CW, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Moon DH, Park SW, Park SJ. Clin Cardiol; 2019 Feb; 42(2):241-246. PubMed ID: 30537083 [Abstract] [Full Text] [Related]
24. Does Vascular Calcification Accelerate Inflammation?: A Substudy of the dal-PLAQUE Trial. Joshi FR, Rajani NK, Abt M, Woodward M, Bucerius J, Mani V, Tawakol A, Kallend D, Fayad ZA, Rudd JH. J Am Coll Cardiol; 2016 Jan 05; 67(1):69-78. PubMed ID: 26764069 [Abstract] [Full Text] [Related]
25. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. J Vis Exp; 2012 May 02; (63):e3777. PubMed ID: 22588186 [Abstract] [Full Text] [Related]
26. Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. Ripa RS, Zobel EH, von Scholten BJ, Jensen JK, Binderup T, Diaz LJ, Curovic VR, Hansen TW, Rossing P, Kjaer A. Circ Cardiovasc Imaging; 2021 Jul 02; 14(7):e012174. PubMed ID: 34187185 [Abstract] [Full Text] [Related]
27. Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake. Vlachopoulos C, Koutagiar I, Skoumas I, Terentes-Printzios D, Zacharis E, Kolovou G, Stamatelopoulos K, Rallidis L, Katsiki N, Bilianou H, Liberopoulos E, Miliou A, Kafouris P, Georgakopoulos A, Gardikioti V, Tousoulis D, Anagnostopoulos CD. JACC Cardiovasc Imaging; 2019 Dec 02; 12(12):2573-2574. PubMed ID: 31806185 [No Abstract] [Full Text] [Related]
28. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A. Circ Cardiovasc Imaging; 2016 Dec 02; 9(12):e004195. PubMed ID: 27956407 [Abstract] [Full Text] [Related]
29. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report. Hippe DS, Phan BAP, Sun J, Isquith DA, O'Brien KD, Crouse JR, Anderson T, Huston J, Marcovina SM, Hatsukami TS, Yuan C, Zhao XQ. Arterioscler Thromb Vasc Biol; 2018 Mar 02; 38(3):673-678. PubMed ID: 29301785 [Abstract] [Full Text] [Related]
30. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Taqueti VR, Di Carli MF, Jerosch-Herold M, Sukhova GK, Murthy VL, Folco EJ, Kwong RY, Ozaki CK, Belkin M, Nahrendorf M, Weissleder R, Libby P. Circ Cardiovasc Imaging; 2014 Nov 02; 7(6):920-9. PubMed ID: 25170063 [Abstract] [Full Text] [Related]
31. Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation. Oh M, Kim H, Shin EW, Sung C, Kim DH, Moon DH, Lee JS, Lee PH, Lee SW, Lee CW. Medicine (Baltimore); 2021 Mar 12; 100(10):e25114. PubMed ID: 33725908 [Abstract] [Full Text] [Related]
32. Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis. Ye YX, Calcagno C, Binderup T, Courties G, Keliher EJ, Wojtkiewicz GR, Iwamoto Y, Tang J, Pérez-Medina C, Mani V, Ishino S, Johnbeck CB, Knigge U, Fayad ZA, Libby P, Weissleder R, Tawakol A, Dubey S, Belanger AP, Di Carli MF, Swirski FK, Kjaer A, Mulder WJ, Nahrendorf M. Circ Res; 2015 Oct 23; 117(10):835-45. PubMed ID: 26394773 [Abstract] [Full Text] [Related]
33. Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in Ireland. McCabe JJ, Giannotti N, McNulty J, Collins S, Coveney S, Murphy S, Barry M, Harbison J, Cronin S, Williams D, Horgan G, Dolan E, Cassidy T, McDonnell C, Kavanagh E, Foley S, O'Connell M, Marnane M, Kelly P. BMJ Open; 2020 Jul 19; 10(7):e038607. PubMed ID: 32690537 [Abstract] [Full Text] [Related]
34. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Atherosclerosis; 2013 Jun 19; 228(2):339-45. PubMed ID: 23582588 [Abstract] [Full Text] [Related]
35. Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT. Kaida H, Tahara N, Tahara A, Honda A, Nitta Y, Igata S, Ishibashi M, Yamagishi S, Fukumoto Y. Atherosclerosis; 2014 Dec 19; 237(2):404-9. PubMed ID: 25463065 [Abstract] [Full Text] [Related]
36. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec 19; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
38. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2011 Oct 19; 4(10):1100-9. PubMed ID: 21999870 [Abstract] [Full Text] [Related]
39. Uptake of F-18 FDG and ultrasound analysis of carotid plaque. Choi YS, Youn HJ, Chung WB, Hwang HJ, Lee DH, Park CS, Lee JB, Kim PJ, Chung WS, Lee MY, Seung KB, Chung YA. J Nucl Cardiol; 2011 Apr 19; 18(2):267-72. PubMed ID: 21279492 [Abstract] [Full Text] [Related]
40. Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. Yang SJ, Kim S, Hwang SY, Kim TN, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Atherosclerosis; 2012 Feb 19; 220(2):402-6. PubMed ID: 22137663 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]